What Is Familial Hypercholesterolaemia & What Causes It?
FH is one of many genetic disorders that can negatively affect your heart, like some connective tissue disorders. In this instance, your liver cannot effectively remove low-density lipoproteins (LDL) from your blood. This bad cholesterol then stays in the blood and begins to build up in your arteries, making it harder for your heart to function as normal. As the condition is genetic, and therefore present from birth, this build-up begins from childhood.
Higher-than-normal levels of bad cholesterol increase your chance of a range of heart diseases, including heart attacks, and also can affect your life expectancy. When left untreated, the prognosis gets worse as the person ages (with some differences between genders). The condition seems to affect males more severely than females, and It is estimated that 50% of men with FH will have a heart attack by age 50.
It’s important to note that FH is different to typical ‘high cholesterol’ (also called dyslipidaemia) because it is a genetic condition. Where common dyslipidaemia is generally caused by an unhealthy lifestyle, FH is due to a genetic mutation that affects how your liver processes LDL or bad cholesterol.
Additionally, FH can vary between individuals, even those in the same family. Therefore, one person may develop progressive heart issues, while another stays stable. Another again may have minor changes that can only be detected by a cardiologist who is experienced with FH.
Several genes have been identified to be associated with FH. These are:
- LDLR (This is the most commonly affected gene.)
- LDLRAP1
- APOB
- PCSK9
The above genes all affect how the body regulates and removes cholesterol, with approximately 60–80% of those with FH having a mutation in at least one of these genes.
Genetic mutations can be passed down from parents (inherited) or occur spontaneously at conception (known as ‘de novo’ mutation). FH is mostly an autosomal dominant disorder. meaning only one member of a gene pair needs to have the mutation for the condition to be present. This means that if a parent has the disorder, there is a 50% chance that they will pass it on to their children. When this occurs, the child has what is known as dominant familial hypercholesterolemia.
In rare cases, a child may inherit two copies of the same mutation. As a result, they will develop a different type of FH: recessive familial hypercholesterolemia. Recessive FH is more serious as it results in even higher levels of cholesterol and heart attacks are likely to begin in childhood. If both parents have FH, there is a 25% chance their child will have the recessive type of FH.
It is possible for a person to spontaneously develop the genetic mutations that cause FH (heterozygous or homozygous) at conception (this is known as a ‘de novo’ mutation. This can then mean that they have the condition but have no family history of it.
Whether the mutation is inherited or de novo, the child is at risk from birth of developing the disease. Unfortunately, it is not possible to reverse the mutation or completely remove the possibility of the disease developing. The best way to be proactive when working with the possibility of FH is to aim for an early diagnosis. This is vital for improving life expectancy and quality of life.
Genetic testing can be used to determine if a person has FH. This can then allow for quicker diagnosis and treatment before those more serious stages are reached, as well as helping families plan how to minimise passing the condition on to their children.